中文
ENGLISH
Home
About Us
News
Products
EHS Management
Recruitment
Contact Us
中文版
Search
Categories
Diabetes series
Canagliflozin and intermediates
Dapagliflozin and intermediates
Empagliflozin and intermediates
Sotagliflozin and intermediates
Ipragliflozin and intermediates
Ertugliflozin and intermediates
Repaglinide and intermediates
Sitagliptin and intermediates
Features intermediates
Rivaroxaban and intermediates
Tofacitinib and intermediates
Baricitinib
Crizotinib
Larotrectinib
Research project
Elagolix
Filgotinib
Baloxavir
Imeglimin
PF-04965842
Ritlecitinib
Upadacitinib
Iptacopan
Asciminb
Sotorasib
Custom production
Link:
Lian Chuang Biomedicine
Products
Product Name
CAS NO.
Detailes
Classification
Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside
1279691-36-9
Empagliflozin and intermediates
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan
915095-89-5
(S)-(+)-3-Hydroxytetrahydrofuran
86087-23-2
Sotagliflozin
1018899-04-1
Sotagliflozin and intermediates
(5S)-4,5-O-(1-Methylethylidene)-1-C-4-morpholinyl-D-xylo-pentodialdo-5,2-furanose
1103738-19-7
Methyl (5S)-5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-beta-L-xylopyranoside 2,3,4-triacetate
1018899-03-0
Ipragliflozin L-Proline
951382-34-6
Ipragliflozin and intermediates
Ipragliflozin
761423-87-4
(1S)-1,5-Anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol 2,3,4,6-tetraacetate
1034305-21-9
Ertugliflozin
1210344-57-2
Ertugliflozin and intermediates
First
Previous
1
2
3
4
5
6
Next
Last
6
Pages
51
Items
Copyright 2018 Anhui Senji Pharmaceutical Co. , Ltd. All rights reserved.
Admin